The role of biologic therapies in the management of systemic vasculitis.

The role of biologic therapies in the management of systemic vasculitis.

The recent development of biologic therapies capable of selectively targeting components of the immune system has revolutionised the treatment of inflammatory arthritides. The steady increase in use of biologic agents coupled with the expansion in the knowledge of the pathogenesis of vascular inflam...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Chan, A, Flossmann, O, Mukhtyar, C, Jayne, DR, Luqmani, R
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2006

Antzeko izenburuak

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
nork: Mukhtyar, C, et al.
Argitaratua: (2006)

Factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis
nork: Luqmani, R, et al.
Argitaratua: (2007)

Cardiovascular outcomes in ANCA associated vasculitis
nork: Mukhtyar, C, et al.
Argitaratua: (2008)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
nork: Mukhtyar, C, et al.
Argitaratua: (2007)

Clinical and biological assessment in systemic necrotizing vasculitides.
nork: Mukhtyar, C, et al.
Argitaratua: (2006)

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
nork: Mukhtyar, C, et al.
Argitaratua: (2008)

Outcome in small-vessel systemic vasculitis.
nork: Luqmani, R, et al.
Argitaratua: (2006)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
nork: Suppiah, R, et al.
Argitaratua: (2011)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
nork: Flossmann, O, et al.
Argitaratua: (2006)

Cardiovascular involvement in primary systemic vasculitis.
nork: Mukhtyar, C, et al.
Argitaratua: (2009)

Eular recommendations for vasculitis
nork: Luqmani, R, et al.
Argitaratua: (2007)

Outpatient assessment of systemic vasculitis.
nork: Nataraja, A, et al.
Argitaratua: (2007)

Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
nork: Mukhtyar, C, et al.
Argitaratua: (2007)

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.
nork: Suppiah, R, et al.
Argitaratua: (2011)

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
nork: Mukhtyar, C, et al.
Argitaratua: (2007)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
nork: Mukhtyar, C, et al.
Argitaratua: (2008)

Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis
nork: Hellmich, B, et al.
Argitaratua: (2006)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
nork: Luqmani, R, et al.
Argitaratua: (2009)

Long-term survival of ANCA-associated vasculitis
nork: Flossmann, O, et al.
Argitaratua: (2009)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
nork: Luqmani, R, et al.
Argitaratua: (2007)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
nork: Robson, J, et al.
Argitaratua: (2013)

Development of comprehensive disease assessment in systemic vasculitis.
nork: Flossmann, O, et al.
Argitaratua: (2007)

Development of comprehensive disease assessment in systemic vasculitis.
nork: Flossmann, O, et al.
Argitaratua: (2008)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
nork: Mukhtyar, C, et al.
Argitaratua: (2009)

Update on the use of biologics in primary systemic vasculitides.
nork: Mukhtyar, C, et al.
Argitaratua: (2007)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
nork: Walsh, M, et al.
Argitaratua: (2011)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
nork: Robson, J, et al.
Argitaratua: (2013)

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
nork: Suppiah, R, et al.
Argitaratua: (2010)

The future of damage assessment in vasculitis.
nork: Seo, P, et al.
Argitaratua: (2007)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
nork: Mukhtyar, C, et al.
Argitaratua: (2008)

Validation of a new version of the Birmingbam vasculitis activity score
nork: Mukhtyar, C, et al.
Argitaratua: (2008)

Modification and validation of the Birmingham Vasculitis Activity Score (version 3).
nork: Mukhtyar, C, et al.
Argitaratua: (2009)

Long-term patient survival in ANCA-associated vasculitis.
nork: Flossmann, O, et al.
Argitaratua: (2011)

Long-term patient survival in ANCA-associated vasculitis
nork: Flossmann, O, et al.
Argitaratua: (2011)

Discontinuation of therapies in vasculitis.
nork: Luqmani, R
Argitaratua: (2013)

Discontinuation of therapies in vasculitis.
nork: Luqmani, R
Argitaratua: (2013)

Discontinuation of therapies in vasculitis.
nork: Luqmani, R
Argitaratua: (2013)

NEW INSIGHTS INTO THE MANAGEMENT OF SYSTEMIC VASCULITIS
nork: Luqmani, R
Argitaratua: (2012)

An approach to the diagnosis and management of systemic vasculitis.
nork: Miller, A, et al.
Argitaratua: (2010)

Optimisation of cyclophosphamide therapy in systemic vasculitis.
nork: Richmond, R, et al.
Argitaratua: (1998)